|
Powered by Cell Signaling Technology |
| Site Information |
|---|
| LLNTGSyyEHVKIsA SwissProt Entrez-Gene |
| Blast this site against: NCBI SwissProt PDB |
| Site Group ID: 1271626200 |
| In vivo Characterization | |
|---|---|
| Methods used to characterize site in vivo: | |
| Disease tissue studied: | |
| Relevant cell line - cell type - tissue: | |
| Upstream Regulation | |
|---|---|
| Putative in vivo kinases: | |
| Treatments: | |
| Downstream Regulation | |
|---|---|
| Effects of modification on cGAS: | |
| Effects of modification on biological processes: | |
| Induce interaction with: | |
| Inhibit interaction with: | |
| References | |
|---|---|
|
Yang YL, et al. (2022) Endocytosis triggers V-ATPase-SYK-mediated priming of cGAS activation and innate immune response. Proc Natl Acad Sci U S A 119, e2207280119
36252040 Curated Info |
|
|
Jiang H, et al. (2019) Chromatin-bound cGAS is an inhibitor of DNA repair and hence accelerates genome destabilization and cell death. EMBO J 38, e102718
31544964 Curated Info |
|
|
Liu H, et al. (2018) Nuclear cGAS suppresses DNA repair and promotes tumorigenesis. Nature 563, 131-136
30356214 Curated Info |